LBA49 Associations of ctDNA clearance (CL) during neoadjuvant Tx with pathological response and event-free survival (EFS) in pts with resectable NSCLC (R-NSCLC): Expanded analyses from AEGEAN
Martin Reck, Davina Gale, Zhou Zhu, David Harpole, Janis M. Taube, T. Mitsudomi, D. Van Luong, Maximilian J. Hochmair, KY Lee, Yoshitsugu Horio, László Urbán, H. Akamatsu, Bivas Biswas, L. Antonuzzo, Zsuzsanna Szalai, Ross Stewart, Zhongwu Lai, Darren Hodgson, Gary J. Doherty, John V. Heymach
Topics & Concepts
MedicineOncologyInternal medicinePathologicalNeoadjuvant therapyCancerBreast cancerCancer Genomics and DiagnosticsLymphoma Diagnosis and TreatmentLung Cancer Treatments and Mutations